Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTH1R | Q03431 | 9/20 | 0.67 |
| ▸ | GLP1R | P43220 | 7/20 | 0.61 |
| ▸ | ECE1 | P42892 | 1/20 | 0.61 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.61 |
| ▸ | GCGR | P47871 | 1/20 | 0.60 |
| ▸ | GIPR | P48546 | 1/20 | 0.60 |
| ▸ | IL23R | Q5VWK5 | 3/20 | 0.59 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30933208 | 0.97 | PTH1R (0.69) | PTH1RGLP1RIL23RRXFP1 | |
| SCHEMBL30933203 | 0.95 | IL23R (0.64) | PTH1RGLP1RECE1MUS81GCGR | |
| SCHEMBL30431833 | 0.92 | GLP1R (0.65) | PTH1RGLP1RECE1MUS81GCGR | |
| SCHEMBL30428969 | 0.91 | GLP1R (0.63) | PTH1RGLP1RECE1MUS81GCGR | |
| SCHEMBL29396018 | 0.90 | IL23R (0.61) | PTH1RIL23R | |
| SCHEMBL30431773 | 0.90 | PTH1R (0.65) | PTH1RGLP1RECE1MUS81GCGR | |
| SCHEMBL30065622 | 0.90 | GLP1R (0.69) | PTH1RGLP1RECE1MUS81IL23R | |
| SCHEMBL30052890 | 0.89 | KISS1R (0.60) | PTH1RGLP1RECE1MUS81IL23R | |
| SCHEMBL30261961 | 0.89 | PTH1R (0.67) | PTH1RGLP1RECE1MUS81GCGR | |
| SCHEMBL30906455 | 0.89 | GLP1R (0.71) | PTH1RGLP1RECE1MUS81RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240197814-A1 | MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES | OAK CREST INSTITUTE OF SCIENCE | 2024-06-20 | — | — | US | disclosed |
| EP-4308146-A1 | MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES | Oak Crest Institute of Science (US) | 2024-01-24 | — | — | EP | disclosed |
| US-11866460-B2 | Broad-spectrum anti-infective peptides | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2024-01-09 | — | — | US | disclosed |
| US-20230416329-A1 | A PEPTIDE WITH DISULFIDE BONDS AND INHIBITORY ACTIVITY AGAINST SERINE PROTEASES, DERIVED HYBRID PEPTIDES THEREOF, AND USES THEREOF | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2023-12-28 | — | — | US | disclosed |
| EP-3313862-B9 | BROAD-SPECTRUM ANTI-INFECTIVE PEPTIDES | UNIV NANYANG TECH (SG) | 2023-10-04 | — | — | EP | disclosed |
| CN-116615436-A | Disulfide bond-containing polypeptide with serine protease activity inhibiting function, hybrid peptide derived from disulfide bond-containing polypeptide and application of disulfide bond-containing polypeptide | 中国医学科学院药物研究所 | 2023-08-18 | — | — | CN | disclosed |
| US-20230256049-A1 | MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF VIRAL RESPIRATORY DISEASES | OAK CREST INSTITUTE OF SCIENCE | 2023-08-17 | — | — | US | disclosed |
| WO-2022111713-A9 | POLYPEPTIDE CONTAINING DISULFIDE BONDS AND CAPABLE OF INHIBITING ACTIVITY OF SERINE PROTEASE, DERIVED HYBRID PEPTIDE THEREOF, AND USE THEREOF | 中国医学科学院药物研究所 | 2023-07-27 | — | — | WO | disclosed |
| EP-3313862-B1 | BROAD-SPECTRUM ANTI-INFECTIVE PEPTIDES | UNIV NANYANG TECH (SG) | 2023-06-07 | — | — | EP | disclosed |
| EP-4171746-A1 | MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF VIRAL RESPIRATORY DISEASES | Oak Crest Institute of Science (US) | 2023-05-03 | — | — | EP | disclosed |
| US-20220402972-A1 | BROAD-SPECTRUM ANTI-INFECTIVE PEPTIDES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2022-12-22 | — | — | US | disclosed |
| WO-2022232275-A1 | MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES | OAK CREST INSTITUTE OF SCIENCE (US) | 2022-11-03 | — | — | WO | disclosed |
| CN-114573686-A | Polypeptide containing disulfide bond and having serine protease activity inhibition function and application thereof | 中国医学科学院药物研究所 | 2022-06-03 | — | — | CN | disclosed |
| WO-2022111713-A1 | POLYPEPTIDE CONTAINING DISULFIDE BONDS AND CAPABLE OF INHIBITING ACTIVITY OF SERINE PROTEASE, DERIVED HYBRID PEPTIDE THEREOF, AND USE THEREOF | 中国医学科学院药物研究所 | 2022-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230416329-A1 | A PEPTIDE WITH DISULFIDE BONDS AND INHIBITORY ACTIVITY AGAINST SERINE PROTEASES, DERIVED HYBRID PEPTIDES THEREOF, AND USES THEREOF | VIP, SI, TMPRSS15 | PTH1R 419/4885GLP1R 310/4885ECE1 196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.